Scribe Therapeutics, Inc. (SCTX)
15.97
+0.49
(+3.17%)
USD |
NASDAQ |
Nov 06, 10:08
Scribe Therapeutics Profit Margin (Quarterly) : -337.7% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -337.7% |
| March 31, 2026 | -776.8% |
| Date | Value |
|---|---|
| June 30, 2025 | -202.2% |
| March 31, 2025 | -20.00% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -42.79% |
| Twist Bioscience Corp. | -29.61% |
| Veracyte, Inc. | 20.76% |
| Cypherpunk Technologies, Inc. | -- |
| Nurix Therapeutics, Inc. | 81.69% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 59.07% |
| Operating Margin (Quarterly) | -489.8% |